2025 third_quarter Filing

Income

$50K

Filed

October 20, 2025

Lobbying Activities

Trade (domestic/foreign)View all

IP Protections related to trade agreements; trade policies impacting pharmaceutical development; potential tariff actions under Section 232 of the Trade Act of 1962. Legislative proposals related to WTO TRIPS Waiver.

Contacted:HOUSE OF REPRESENTATIVES, SENATE

Medicare/MedicaidView all

General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. IPI drug pricing proposal, Medicare Rebate Rule. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 1492 and S. 832. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.

HOUSE OF REPRESENTATIVES, SENATE

Lobbyists (3)

SUSAN HIRSCHMANN

mr MATTHEW B HOEKSTRA

JEANNE HAGGERTY

Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member